You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
12 October 2026 - Danish biopharmaceutical company TETRAPHARM announced on Friday that it has appointed Rolf Sass Sorensen as its new chief executive officer.He succeeds Martin Rose, who founded the company along with Jesper Breum in 2018.This leader...
12 October 2026 - Perceptive Discovery, a preclinical and translational research organisation supporting oncology, CNS, and radiopharmaceutical development, announced on Friday that it has formed a strategic partnership with CDMO Nucleus RadioPharma ...
12 October 2026 - Chinese biopharmaceutical company Akeso Inc (HKEX:9926) announced on Saturday that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispe...
9 October 2026 - Medical device company Urolution Medical Inc announced on Friday that it has received US Food and Drug Administration (FDA) 510(k) clearance for its OpenFlo Urinary Catheter, advancing the company toward clinical evaluation and comme...
9 October 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ:NTRA) announced on Friday that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its multi-cancer early detection (MCED) assay, su...
9 October 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab ...
9 October 2026 - Clinical-stage biotechnology company Alpheus Medical Inc announced on Thursday the launch of a new clinical trial evaluating its investigational Porphyrin Metabolite Activation (PoMA) therapy in patients with butterfly glioblastoma (...